Poor Pfizer. Two piles of steaming trouble on the same day:
1 What they do: they decide to combine amlodipine and atorvastatin into one tablet.
That's gone down badly in most of Europe. Pfizer has now decided to withdraw its application for Caduet in Belgium, Denmark, Estonia, Ireland, Italy, the Netherlands, Norway, the UK, Sweden, Germany, Finland, and Greece.
2 The way that they do it: the U.S. Department of Justice has requested information about payments by the drug giant to physicians concerning prescription medicines.
That's not playing too well on home territory, either.
Cheer up Hank. Not long to go now. As you said recently, retirement is looking pretty good after 35 years in the business!
Source: WSJ
2 comments:
What and give patient's responsibility in this patientled NHS ? What about my GMS points ?
You clearly practice IBM (income based medicine) rather than EBM (evidence based medicine)!! ;-)
Post a Comment